These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14974059)

  • 1. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.
    Ashworth NL; Satkunam LE; Deforge D
    Cochrane Database Syst Rev; 2004; (1):CD004156. PubMed ID: 14974059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.
    Ashworth NL; Satkunam LE; Deforge D
    Cochrane Database Syst Rev; 2012 Feb; (2):CD004156. PubMed ID: 22336799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.
    Ashworth NL; Satkunam LE; Deforge D
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004156. PubMed ID: 16437474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.
    Dalbello-Haas V; Florence JM; Krivickas LS
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005229. PubMed ID: 18425913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.
    Dal Bello-Haas V; Florence JM
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD005229. PubMed ID: 23728653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acids for amyotrophic lateral sclerosis / motor neuron disease.
    Parton M; Mitsumoto H; Leigh PN
    Cochrane Database Syst Rev; 2003; (4):CD003457. PubMed ID: 14583978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.
    Radunovic A; Annane D; Rafiq MK; Mustfa N
    Cochrane Database Syst Rev; 2013 Mar; (3):CD004427. PubMed ID: 23543531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.
    Mitchell JD; Wokke JH; Borasio GD
    Cochrane Database Syst Rev; 2002; (3):CD002064. PubMed ID: 12137643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.
    Radunovic A; Annane D; Jewitt K; Mustfa N
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004427. PubMed ID: 19821325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease.
    Baldinger R; Katzberg HD; Weber M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD004157. PubMed ID: 22513921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.
    Mitchell JD; Wokke JH; Borasio GD
    Cochrane Database Syst Rev; 2007 Oct; (4):CD002064. PubMed ID: 17943766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease.
    Beauverd M; Mitchell JD; Wokke JH; Borasio GD
    Cochrane Database Syst Rev; 2012 Nov; 11():CD002064. PubMed ID: 23152212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WITHDRAWN: Amino acids for amyotrophic lateral sclerosis / motor neuron disease.
    Parton M; Mitsumoto H; Leigh PN
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003457. PubMed ID: 18425887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease.
    Guo J; Zhou M; Yang M; Zhu C; He L
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008554. PubMed ID: 21901724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis/motor neuron disease.
    Bongioanni P; Reali C; Sogos V
    Cochrane Database Syst Rev; 2004; 2004(3):CD004302. PubMed ID: 15266526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease.
    Orrell RW; Lane JM; Ross MA
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002829. PubMed ID: 15495036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease.
    Orrell RW; Lane RJ; Ross M
    Amyotroph Lateral Scler; 2008 Aug; 9(4):195-211. PubMed ID: 18608090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease.
    Brettschneider J; Kurent J; Ludolph A; Mitchell JD
    Cochrane Database Syst Rev; 2008 Jul; (3):CD005226. PubMed ID: 18646122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
    Riva N; Mora G; Sorarù G; Lunetta C; Ferraro OE; Falzone Y; Leocani L; Fazio R; Comola M; Comi G;
    Lancet Neurol; 2019 Feb; 18(2):155-164. PubMed ID: 30554828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease.
    Orrell RW; Lane RJ; Ross M
    Cochrane Database Syst Rev; 2005 Jan; (1):CD002829. PubMed ID: 15674899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.